ArticleACS pharmacology & translational science2020

Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay.

Quinlin M Hanson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.